证券Ⅱ

Search documents
5月28日晚间重要公告一览
Xi Niu Cai Jing· 2025-05-28 10:18
中国能建:中标145.86亿元重大煤电项目 5月28日晚,中国能建(601868)发布公告称,公司所属子公司组成的联合体中标中新建电力兵准园区 6×66万千瓦煤电项目(EPC),中标金额约145.86亿元。该项目包括6台66万千瓦超超临界燃煤发电机 组及配套环保设施,总工期约36.5个月。目前尚未正式签署合同。 资料显示,中国能建成立于2014年12月,主营业务是勘测设计及咨询、工程建设、工业制造、投资运 营。 所属行业:建筑装饰–基础建设–基建市政工程 友讯达:中标国家电网1.76亿元项目 5月28日晚,友讯达(300514)发布公告称,公司在国家电网有限公司2025年第三十一批采购(营销项 目第一次计量设备招标采购)中中标10个包,中标金额约为1.76亿元,占公司2024年经审计营业收入的 17.44%。 资料显示,友讯达成立于2002年9月,主营业务是各行业综合物联网问题的服务、帮助和解决。 所属行业:电力设备–电网设备–电工仪器仪表 岱勒新材:与专业机构共同设立投资基金 5月28日晚,岱勒新材(300700)发布公告称,公司与泰诺(深圳)私募股权基金管理有限公司等机构 签署协议,共同投资设立深圳泰诺协 ...
非银行业周报:科技金融体制构建提速
Tai Ping Yang· 2025-05-20 02:50
2025 年 05 月 18 日 行业周报 看好/维持 非银行金融 非银行金融 非银行业周报(0512-0518):科技金融体制构建提速 ◼ 走势比较 (20%) (4%) 12% 28% 44% 60% 24/5/20 24/7/31 24/10/11 24/12/22 25/3/4 25/5/15 ◼ 子行业评级 | 证券Ⅱ | 看好 | | --- | --- | | 保险Ⅱ | 看好 | | 多元金融 | 看好 | | ◼ 推荐公司及评级 | | | 方正证券 | 买入 | | 湘财股份 | 买入 | | 中国人寿 | 买入 | | 众安在线 | 增持 | 相关研究报告 <<众安在线 2024 年年报点评:科技 赋能驱动增长,投资收益大幅提 升>>--2025-05-15 <<非银行业周报(0505-0511):增量 政策出台稳定市场预期>>--2025- 05-12 证券分析师:夏芈卬 电话:010-88695119 E-MAIL:xiama@tpyzq.com 分析师登记编号:S1190523030003 研究助理:王子钦 E-MAIL:wangziqin@tpyzq.com 一般证券业务登记编号 ...
证监会修改发布《上市公司重大资产重组管理办法》点评:并购政策进一步松绑,鼓励优质企业做大做强
Shenwan Hongyuan Securities· 2025-05-17 14:41
行 业 及 产 业 非银金融/ 证券Ⅱ 行 业 研 究 / 行 业 点 评 证 券 研 究 报 告 联系人 事件:2025 年 5 月 16 日,证监会修改发布《上市公司重大资产重组管理办法》(以下简称 《管理办法》)。 《管理办法》的修改发布核心在于对并购重组政策进一步松绑,鼓励优质企业通过并购重组方 式做大做强。本次《管理办法》修改涉及修改项目 22 条,主要看点有五:1)建立重组股份对 价分期支付机制: 将申请一次注册、分期发行股份购买资产的注册决定有效期延长至 48 个 月。 这意味着上市公司在进行重大资产重组时,可以根据实际情况,分期发行股份来购买资 产,且注册决定有效期的延长,为上市公司提供了更充裕的时间来完成整个重组过程,增加了 重组操作的灵活性,有助于提高重组的成功率。2)提高对财务状况变化、同业竞争和关联交 易监管的包容度:此前,监管部门对上市公司重大资产重组中的财务状况变化、同业竞争和关 联交易等问题的监管较为严格,要求披露重组对相关事项的积极作用。此次提高包容度,表明 监管部门更注重企业实际情况和发展需求,从而使更多企业有机会通过重大资产重组实现资源 整合。3)新设重组简易审核程序: 明 ...
5月13日晚间重要公告一览
Xi Niu Cai Jing· 2025-05-13 10:21
Group 1 - Shengyi Electronics plans to repurchase shares with a total amount between 50 million and 100 million yuan, at a price not exceeding 43.02 yuan per share, for employee stock ownership plans [1] - Guoyao Modern's subsidiary has passed the consistency evaluation for the quality and efficacy of a generic drug, which is used for treating severe infections [1] - Tianhe Magnetic Materials' subsidiaries have obtained project filing notices for high-performance rare earth permanent magnet projects, with total investments of 100 million yuan and 50 million yuan respectively [1][2] Group 2 - Dream Lily intends to repurchase shares with an amount between 85 million and 170 million yuan, at a price not exceeding 10.90 yuan per share, supported by a loan commitment of up to 150 million yuan [3] - Weifu High-Tech has received a loan commitment of up to 135 million yuan from a financial institution for share repurchase [3] Group 3 - Lu'an Environmental Energy reported a coal sales volume of 4.51 million tons in April, a year-on-year increase of 17.75% [5] - *ST Tianshan reported a significant decline in livestock sales and revenue, with a revenue of 70,500 yuan in April, down 95.68% year-on-year [7] Group 4 - Feirongda announced a cash dividend of 0.38 yuan per 10 shares, with a total distribution of 21.9 million yuan [8] - Zhejiang Rongtai's shareholders and executives plan to reduce their holdings by up to 1.93% of the company's shares [9] Group 5 - Changhua Group's subsidiary won the land use rights for an industrial site in Ningbo for 27.05 million yuan, intended for manufacturing and related business [11] - Zejing Pharmaceutical's new drug application for a treatment for severe alopecia has been accepted by the regulatory authority [13][14] Group 6 - Hainan Mining plans to distribute a cash dividend of 0.8 yuan per 10 shares, totaling 1.59 billion yuan [15] - China Jushi plans to distribute a cash dividend of 0.24 yuan per share, totaling 9.61 billion yuan [16] Group 7 - Zhengzhong Design's subsidiary has obtained a utility model patent for an acrylic signage guide [18] - Rundu Co., Ltd. received approval for a veterinary drug product, which is intended for treating bacterial diseases in livestock [20] Group 8 - Emei Mountain A announced the resignation of its general manager due to work reasons [22] - Tonghua Dongbao's insulin injection has received a registration certificate in Nicaragua, allowing for sales in that market [23] Group 9 - Dizu Fashion's subsidiary has completed the registration of a private equity investment fund [24] - Ningbo Gaofa plans to increase capital by 60 million yuan in its subsidiary for operational needs [26] Group 10 - Haichuan Intelligent has obtained two utility model patents for material handling devices [27] - Newland's subsidiary signed a deep cooperation agreement with Alibaba Cloud for AI model applications [29] Group 11 - Rui Neng Technology's controlling shareholder plans to reduce its stake by up to 2.89% [30] - Guomai Culture intends to repurchase shares between 50 million and 100 million yuan for capital reduction [31] Group 12 - Shaanxi Construction won major construction projects totaling 7.88 billion yuan in April [32] - Hanyu Pharmaceutical signed a joint development agreement for a new peptide drug with a partner [34] Group 13 - Yunnan Copper is planning to acquire a 40% stake in Liangshan Mining, leading to a stock suspension [35] - Haizheng Pharmaceutical plans to repurchase shares between 50 million and 100 million yuan for employee stock ownership [36] Group 14 - Tianqiao Hoisting's controlling shareholder plans to increase its stake by 75 million to 150 million yuan [37] - Tiandi Online's controlling shareholder is transferring shares to introduce a strategic investor [38] Group 15 - Hongchang Technology plans to invest 15 million yuan in a joint venture with a partner [39] - Rabbit Baby's subsidiary is preparing for an IPO in Hong Kong [41] Group 16 - Wol Nuclear Materials is planning to issue H-shares for listing in Hong Kong [42] - Tangyuan Electric plans to raise up to 864 million yuan through a private placement for various projects [43] Group 17 - Tongrun Equipment's major shareholders plan to reduce their holdings by up to 2% [44] - Linzhou Heavy Machinery plans to raise up to 600 million yuan through a private placement [46] Group 18 - China Merchants Securities announced the resignation of its vice president [47] - Shangsheng Electronics plans to issue convertible bonds to raise up to 330 million yuan for various projects [48] Group 19 - Longda Co., Ltd.'s major shareholder plans to reduce its stake by up to 1% [49] - China Medical plans to acquire 100% of Jinsui Technology for 302 million yuan [50] Group 20 - Silek has signed a strategic cooperation agreement with a battery manufacturer [51] - Boyun New Materials' major shareholder plans to reduce its stake by up to 3% [53]
华泰证券:25年一季报点评:业绩高增,经纪、信用与自营业务为主要推动力-20250501
Tianfeng Securities· 2025-05-01 14:23
公司报告 | 公司定期报告点评 华泰证券(601688) 证券研究报告 业绩高增,经纪、信用与自营业务为主要推动力—25 年一季报点评 【重资产业务:信用业务与自营业务大幅回暖,助力整体业绩高增】 信用业务方面,25 年 Q1 公司实现信用业务收入 9.7 亿元,同比+319.5%;两融市场 活跃度提升,25 年一季度末两融余额为 19186 亿元,较 24 年同期+24.8%;同时叠 加公司有息债务规模及资金成本下降,导致利息支出减少,共同助力公司信用业务 收入大幅回暖。 自营业务方面,25 年 Q1 公司实现自营业务收入 27.6 亿元,同比+46.5%。25 年 Q1 公司自营金融资产规模为 3854.7 亿元,同比-15.6%,但投资收益率出现较大改善, 25Q1 投资收益率上升 1.34Pct 至 2.92%,在 25Q1 市场股市债市未有大幅上行的情况 下,公司投资收益率的大幅改善凸显公司自营业务的韧性与投资策略的稳健。 投资建议:我们认为,公司在财富管理、投资交易等核心业务水平处于行业领先地 位,同时政策提出稳住股市,"持续稳定和活跃资本市场",在未来成交量有望保持 稳定或有望进一步提升的情况下 ...
华泰证券(601688):25年一季报点评:业绩高增,经纪、信用与自营业务为主要推动力
Tianfeng Securities· 2025-05-01 07:44
公司报告 | 公司定期报告点评 华泰证券(601688) 证券研究报告 业绩高增,经纪、信用与自营业务为主要推动力—25 年一季报点评 【信用与自营业务收入大幅提升,带动净利润高增】 华泰证券 25 年 Q1 实现调整后营收 73 亿元,同比+28.2%;实现归母净利 润 36 亿元,同比+59.0%。公司经纪、信用与自营业务为业绩高增的主要 推手, 经 纪 / 投 行 / 资 管 / 信 用 / 自营营收同比增速分别为 +42.6%/-5.9%/-61.7%/+319.5%/+46.5%。ROE 为 8.4%,较 24 年同期+2.9Pct; 杠杆率下滑 0.69x 至 3.27x。 【轻资产业务:经纪业务受市场提振大幅上升,其余轻资产业务略有承压】 经纪业务方面,公司 25 年 Q1 实现经纪业务收入 19.4 亿元,同比+42.6%,25 年一 季度市场成交量改善明显,25 年 Q1 累计股基日均成交额 17465 亿,较 24 年同期 同比+70.9%,资本市场交投回暖为经纪业务收入增长的主要原因,也为公司持续打 造兼具规模化优势与专业化特色的一流财富服务平台打好坚固的基础。 投行业务方面,公司 25 ...
业务整合推进,自营投资反转
Guoxin Securities· 2025-05-01 01:05
证券研究报告 | 2025年04月30日 国联民生(601456.SH) 优于大市 业务整合推进,自营投资反转 公司发布 2025 年一季报。2025Q1,公司实现营收 15.62 亿元,同比+800.98%; 实现归母净利润 3.76 亿元,同比+271.95%;EPS 为 0.08 元,同比+200.00%; ROE 为 0.96%,同比+2.19pct。分条线看,一季度投资、经纪、投行、资管、 信用业务分别实现收入 7.09、4.69、1.74、1.62、-0.05 亿元,同比分别为 +573.27%、+333.69%、+124.54%、+13.82%、+82.53%。投资业务表现靓丽, 经纪业务大幅提升,助力一季度业绩提升。 自营投资:TPL 和 OCI 权益持续构建,自营规模扩张。2025Q1,公司自营实 现营业收入 7.09 亿元,同比+573.27%;公司金融投资资金较年初增加 351.9 亿元,季末持仓 838.76 亿元,同比+72.29%,其中,TPL 账户增加 278 亿元, 季末持仓 656.87 亿元,同比+73.22%;OCI 权益账户增加 60 亿元,季末持仓 112 亿元,同比 ...
国泰海通(601211):实现强强联合,各业务条线蓄力齐发提升业绩
Tianfeng Securities· 2025-04-30 14:24
公司报告 | 公司定期报告点评 国泰海通(601211) 证券研究报告 【合并后 25 年一季度业绩高增,各业务条线收入均有提升】 国泰海通 25 年 Q1 实现调整后营收 102 亿元,同比+54.4%;实现归母净利润 122 亿 元,同比+391.8%,主要系吸收合并海通证券产生的负商誉带来营业外收入增加; 扣非净利润为 33 亿元,同比+60.7%。各业务条线均发力增厚业绩,经纪/投行/资管 /自营/信用营收同比增速分别为+77.0%/+10.3%/+27.2%/+68.7%/+97.9%。年化 ROE 为 25.8%,较去年同期+19.6Pct;杠杆率下降至 4.28x。 【市场交投活跃,手续费业务收入均表现亮眼】 1)经纪业务:公司 25 年 Q1 实现经纪业务收入 26.5 亿元,同比+77.0%,市场交投 活跃,成交量大幅上行提升公司经纪业务收入,25 年 Q1 累计股基日均成交额为 17465 亿元,较去年同期同比+70.9%,公司经纪收入增速高于市场成交量增速,财 富管理转型成效显著。 2)投行业务:公司 25 年 Q1 实现投行业务收入 7.1 亿元,同比+10.3%,投行业务 收入自 2 ...
华泰证券(601688):自营反转,科技赋能
Guoxin Securities· 2025-04-30 11:16
证券研究报告 | 2025年04月30日 华泰证券(601688.SH) 优于大市 自营反转,科技赋能 华泰证券公布 2025 年一季度报告。2025 年一季度,公司实现营业收入 82.32 亿元,同比提升 34.83%;实现归母净利润 36.42 亿元,同比提升 58.97%;扣 除非经常性损益后的净利润为 36.14 亿元,同比提升 61.42%,对应 EPS0.38 元,同比增长 58.33%;ROE 为 2.1%,同比增 0.73pct。业绩上涨主要因资本 市场回暖,公司财富管理、机构业务、投资管理及信用业务等主要业务线均 同比显著增长,后续公司持续推进科技赋能下的"双轮驱动"发展战略,围 绕数字化、平台化、生态化理念,完善 FICC 代客体系,探索"AI 智能提升", "业务+科技"交融提升价值。 自营、利息业绩成业绩增长主要驱动力。一季度,因权益、衍生品、股权市 场回暖,投资规模和收益率增长驱动投资收入大幅提升,当期实现投资业务 收入(含公允价值变动)9.65 亿元,同比提升 46.53%;公司金融资产规模 3855 亿元,比 2024 年末提升 4.24%。一季度,利息净收入 9.65 亿元,同 ...
财通证券(601108):2024年报及2025一季报点评:财富管理转型成效明显,一季报自营投资拖累业绩
KAIYUAN SECURITIES· 2025-04-27 14:12
Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company's wealth management transformation has shown significant results, although the self-operated investment has negatively impacted performance in the first quarter [4][5] - The total revenue and net profit for 2024 were 6.29 billion and 2.34 billion yuan, respectively, with a year-on-year change of -4% and +4%, aligning with expectations [4] - The first quarter of 2025 saw total revenue and net profit of 1.07 billion and 290 million yuan, respectively, reflecting a year-on-year decline of -24% and -37%, which was below expectations [4] - The company has adjusted its net profit forecasts for 2025 and 2026 to 2.4 billion and 3.2 billion yuan, respectively, down from previous estimates [4] Financial Performance Summary - The company reported a weighted average ROE of 6.59% for 2024, a slight decrease of 0.08 percentage points year-on-year [4] - The first quarter of 2025 showed an annualized weighted average ROE of 3.16%, down by 2.1 percentage points year-on-year [4] - The company's self-operated investment income decreased significantly, with a year-on-year drop of -95% in Q1 2025, attributed to a weakening bond market [6] - The company's total assets were projected to grow from 133.75 billion yuan in 2023 to 190.26 billion yuan by 2027 [9] Business Segment Performance - The brokerage net income for 2024 and Q1 2025 was 1.41 billion and 420 million yuan, respectively, with year-on-year increases of +18% and +41% [5] - Investment banking net income for 2024 and Q1 2025 was 520 million and 110 million yuan, respectively, reflecting declines of -31% and -24% due to a sluggish primary market [5] - Asset management net income for 2024 and Q1 2025 was 1.55 billion and 260 million yuan, with a slight decrease of -0.3% and a more significant drop of -18% [5] Valuation Metrics - The current stock price corresponds to a price-to-book ratio (PB) of 0.9 for 2025, 0.9 for 2026, and 0.8 for 2027 [4] - The earnings per share (EPS) estimates for 2025, 2026, and 2027 are 0.52, 0.68, and 0.78 yuan, respectively [9] - The company’s projected net profit margins are expected to improve from 37.2% in 2024 to 43.7% by 2027 [9]